Archive

November 4, 2025

Browsing

The post Ripple Swell 2025 Live: IPO Talks Ignite with BlackRock and Nasdaq on Stage appeared first on Coinpedia Fintech News

Ripple Swell 2025 is underway in New York City, bringing together global financial leaders, blockchain innovators, and institutional partners. At the event, the Nasdaq CEO announced that over 17 crypto companies are waiting for IPO approval once the U.S. government shutdown ends, showing rising institutional demand for digital assets. 

She said this marks the next big wave of crypto listings that could unlock billions in capital. Adding to the excitement, BlackRock executives also took the stage, opening up about the company’s growing focus on blockchain, tokenization, and stablecoin-backed investments.

This year’s Swell comes at a defining moment for Ripple. 

After a series of acquisitions and global partnerships, the company is positioning itself as a bridge between traditional finance and digital assets. Industry insiders expect Ripple to highlight how it plans to scale its institutional services, focusing on liquidity, custody, and on-chain settlement solutions.

Ripple’s launch of Ripple Prime, a new spot prime brokerage service for institutions, will likely take center stage. The service allows clients to trade spot and digital assets under full compliance, marking Ripple’s first step into the prime brokerage sector traditionally dominated by global investment banks.

Focus on Stablecoins and Treasury Integration

Ripple’s RLUSD stablecoin is expected to be a major talking point. RLUSD, designed for enterprise and cross-border use, could serve as a key component in Ripple’s expanding liquidity ecosystem. Experts anticipate new updates on how RLUSD will integrate with Ripple Prime and GTreasury, which provides cash and treasury management tools to Fortune 500 companies.

This integration could signal a deeper move into corporate finance, allowing global firms to manage funds and payments directly on-chain.

New Partnerships and Global Rollouts

Ripple Swell has often been the stage for unveiling major partnerships, and 2025 should be no different. The company is expected to announce new banking collaborations and possibly expand its network in regions like Asia, the Middle East, and Europe.

Given Ripple’s push toward institutional adoption, announcements related to tokenization, cross-border settlement, and treasury automation are likely. The event may also provide updates on how Ripple’s technologies are being integrated into traditional payment systems and regulatory frameworks.

Beyond announcements, Swell 2025 is expected to deliver insights into how Wall Street and blockchain are converging. Panels featuring executives from global financial institutions will discuss blockchain adoption, regulatory clarity, and the next phase of digital finance.

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States.

Shares of Kenvue were up 18% in premarket trading, while Kimberly-Clark‘s shares were down 12.5%.

Kenvue has been under a strategic review, leadership shake-up, and mounting litigation risks. It came under fresh scrutiny following President Donald Trump’s comments linking its popular pain medicine Tylenol to autism.

The deal will bring together brands including Neutrogena, Huggies and Kleenex under a consumer health and personal care company with expected combined annual revenues of roughly $32 billion.

Sources in June told Reuters the strategic review of its operations could include a sale or breakup of the company that had been spun off from healthcare conglomerate Johnson & Johnson JNJ.N in 2023.

Kenvue‘s shareholders will receive $3.50 per share and 0.15 Kimberly-Clark shares for each Kenvue share held. That implies a per-share deal value of $21.01, or an equity value of $40.32 billion, according to Reuters calculations.

This post appeared first on NBC NEWS

Tesla stock fell in early trading on Tuesday as investor uncertainty mounted over Chief Executive Elon Musk’s proposed $1 trillion compensation package.

The decline comes just days before shareholders vote on the plan, which has divided major institutional investors and reignited debate over Musk’s influence at the electric-vehicle maker.

The stock was down 2.6% at $456.40 in early trading. Broader market weakness added pressure, with S&P 500 futures down 1% and Dow Jones Industrial Average futures off 0.7%.

Coming into Tuesday’s session, Tesla stock was up 16% year-to-date and 93% over the past 12 months, reflecting sustained optimism around its long-term growth story despite short-term turbulence.

Norway’s Sovereign Fund rejects Musk’s pay award

The latest headwind came from Norway’s sovereign wealth fund, which said it would vote against the proposed package.

The $1.9 trillion fund, one of Tesla’s largest institutional shareholders with a 1.2% stake, cited concerns about the “total size of the award, dilution, and lack of mitigation of key person risk.”

“While we appreciate the significant value created under Mr. Musk’s visionary role, we are concerned about the total size of the award, dilution, and lack of mitigation of key person risk—consistent with our views on executive compensation,” the fund said in a statement.

The rejection introduces a degree of uncertainty into the outcome of the November 6 shareholder vote.

Musk’s plan would award him about 425 million incentive-linked shares, designed to raise his voting control to 25%, a level he has said is necessary to oversee Tesla’s artificial intelligence initiatives.

The fund had also opposed Musk’s previous pay package in 2024. Earlier this year, leaked messages revealed tensions between Musk and the fund’s chief executive, Nicolai Tangen, after Musk sent a curt message saying, “friends are as friends do.”

Divided investor base

Norway’s fund is the largest institutional investor to publicly declare its vote on Musk’s package.

Other major stakeholders, including CalPERS and the New York State Retirement Fund, have also voiced opposition.

Proxy advisory firms Glass Lewis and Institutional Shareholder Services (ISS) have recommended that shareholders reject the plan, prompting Musk to label them “corporate terrorists” during Tesla’s recent earnings call.

Not all major investors share that view. Support has come from the Florida State Board of Administration and ARK Invest’s Cathie Wood, both of whom back Musk’s leadership and the company’s AI ambitions.

The two largest shareholders, Vanguard and BlackRock, have not yet disclosed their votes.

Market sentiment remains tense ahead of the shareholder meeting. Wedbush analyst Dan Ives expects investors to approve the plan, calling it “the smart move by the Board to lay out these incentives/pay package at this key time as the biggest asset for Tesla is Musk.”

Ives rates Tesla shares Buy with a $600 price target.

Tesla sales remain under pressure

Tesla’s China-made electric vehicle sales declined 9.9% in October to 61,497 units from a year earlier, reversing a 2.8% gain in September, according to data from the China Passenger Car Association released Tuesday.

Sales of the Model 3 and Model Y vehicles produced at Tesla’s Shanghai gigafactory — including exports to Europe, India, and other markets — fell 32.3% from September.

The company’s global sales momentum has slowed as demand weakens in Europe and uncertainty lingers in the US market following the expiration of tax credits that had supported record deliveries in the third quarter.

In Europe, Tesla’s sales through September were down 28.5% compared with the same period last year amid intensifying competition from legacy automakers and new Chinese brands.

Analysts point to Tesla’s ageing model lineup and limited vehicle range as key factors behind its recent struggles in an increasingly crowded market.

The post Tesla stock down over 2% as Musk pay vote nears: what to expect? appeared first on Invezz